Previous studies have shown the predictive role of Ki-67 in a range of malignancies, including breast cancer, gastrointestinal neuroendocrine tumors, CRC, and so on28–30. Here, MKI67 is linked to digestive system neuroendocrine tumor, grade 1/2.